ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

Raj R Makkar, Ravi K Ramana, Eric Gnall, Basel Ramlawi, Wen Cheng, Pantelis Diamantouros, Srinivasa Potluri, Neal Kleinman, Aakriti Gupta, Tarun Chakravarty, Sanjay Samy, Andrew Rassi, Vivek Rajagopal, Steven Yakubov, Paul Sorajja, Dhairya Patel, Santiago Garcia, Pradeep Yadav, Vinod Thourani, John Wang, Michael Rinaldi, Samir Kapadia, Ron Waksman, John Webb, Claire Ben Ren, John Gregson, Rodrigo Modolo, Janarthanan Sathananthan, Michael J Reardon

Open source

DOI
10.1016/s0140-6736(25)00319-8
Published
2025-06
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-00319-8,
  title = {ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial},
  author = {Raj R Makkar and Ravi K Ramana and Eric Gnall and Basel Ramlawi and Wen Cheng and Pantelis Diamantouros and Srinivasa Potluri and Neal Kleinman and Aakriti Gupta and Tarun Chakravarty and Sanjay Samy and Andrew Rassi and Vivek Rajagopal and Steven Yakubov and Paul Sorajja and Dhairya Patel and Santiago Garcia and Pradeep Yadav and Vinod Thourani and John Wang and Michael Rinaldi and Samir Kapadia and Ron Waksman and John Webb and Claire Ben Ren and John Gregson and Rodrigo Modolo and Janarthanan Sathananthan and Michael J Reardon},
  year = {2025},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(25)00319-8},
  url = {https://doi.org/10.1016/s0140-6736(25)00319-8}
}

RIS

TY  - JOUR
TI  - ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial
AU  - Raj R Makkar
AU  - Ravi K Ramana
AU  - Eric Gnall
AU  - Basel Ramlawi
AU  - Wen Cheng
AU  - Pantelis Diamantouros
AU  - Srinivasa Potluri
AU  - Neal Kleinman
AU  - Aakriti Gupta
AU  - Tarun Chakravarty
AU  - Sanjay Samy
AU  - Andrew Rassi
AU  - Vivek Rajagopal
AU  - Steven Yakubov
AU  - Paul Sorajja
AU  - Dhairya Patel
AU  - Santiago Garcia
AU  - Pradeep Yadav
AU  - Vinod Thourani
AU  - John Wang
AU  - Michael Rinaldi
AU  - Samir Kapadia
AU  - Ron Waksman
AU  - John Webb
AU  - Claire Ben Ren
AU  - John Gregson
AU  - Rodrigo Modolo
AU  - Janarthanan Sathananthan
AU  - Michael J Reardon
PY  - 2025
JO  - The Lancet
DO  - 10.1016/s0140-6736(25)00319-8
UR  - https://doi.org/10.1016/s0140-6736(25)00319-8
ER  - 

APA

Makkar, R. R., Ramana, R. K., Gnall, E., Ramlawi, B., Cheng, W., Diamantouros, P., Potluri, S., Kleinman, N., Gupta, A., Chakravarty, T., Samy, S., Rassi, A., Rajagopal, V., Yakubov, S., Sorajja, P., Patel, D., Garcia, S., Yadav, P., Thourani, V., Wang, J., Rinaldi, M., Kapadia, S., Waksman, R., Webb, J., Ren, C. B., Gregson, J., Modolo, R., Sathananthan, J., & Reardon, M. J. (2025). ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial. The Lancet. https://doi.org/10.1016/s0140-6736(25)00319-8

Source records